Search Results - "Babcock, Blake D"

High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal by Babcock, Blake D., Aljehani, Mayada A., Jabo, Brice, Choi, Audrey H., Morgan, John W., Selleck, Matthew J., Luca, Fabrizio, Raskin, Elizabeth, Reeves, Mark E., Garberoglio, Carlos A., Lum, Sharon S., Senthil, Maheswari

“…Introduction Adjuvant chemotherapy is recommended in patients with stage II colon cancer with high-risk features (HRF). However, there is no quantification of…”
Get full text

Gastric Cancer Peritoneal Carcinomatosis Risk Score by Ji, Liang, Selleck, Matthew J., Morgan, John W., Xu, Jane, Babcock, Blake D., Shavlik, David, Wall, Nathan R., Langridge, William H., Lum, Sharon S., Garberoglio, Carlos A., Reeves, Mark E., Solomon, Naveenraj, Namm, Jukes P., Senthil, Maheswari

“…Background Gastric cancer (GC) peritoneal carcinomatosis (PC) is associated with a poor prognosis. Although grade, histology, and stage are associated with PC,…”
Get full text

Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review by Shaikh, Mohammad F, Morano, William F, Lee, John, Gleeson, Elizabeth, Babcock, Blake D, Michl, Josef, Sarafraz-Yazdi, Ehsan, Pincus, Matthew R, Bowne, Wilbur B

“…The mouse/murine protein, MDM2, and its human homolog, HDM2, are important negative regulators of the p53 tumor suppressor protein. In normal, untransformed…”
Get more information

Maintaining a Sufficient and Quality Physician Workforce: The Role of For-profit Medical Schools by Babcock, Jessica M., Babcock, Blake D., Schwartz, Marshall Z.

“…Currently, in the United States there is a significant physician workforce shortage. This problem is likely to persist as there is no quick solution. The…”
Get full text

Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells by Thadi, Anusha, Morano, William F, Khalili, Marian, Babcock, Blake D, Shaikh, Mohammad F, Foster, Deshka S, Piazza, Yelena, Gleeson, Elizabeth M, Goldstein, Eve, Steele, Lindsay, Campbell, Paul M, Lin, B O, Pincus, Matthew R, Bowne, Wilbur B

“…We have tested whether the anticancer peptide, PNC-27, that kills cancer cells but not normal cells by binding to cancer cell membrane HDM-2 forming pores,…”
Get full text

Sexual and urinary outcomes in robotic rectal surgery: review of the literature and technical considerations by Luca, Fabrizio, Craigg, Danielle K., Senthil, Maheswari, Selleck, Matthew J., Babcock, Blake D., Reeves, Mark E., Garberoglio, Carlos A.

“…Several studies have reported high rates of urogenital dysfunction after open and laparoscopic surgery for rectal cancer. Robotic surgery has several features…”
Get full text

Palliative Surgery for Advanced Cancer: Identifying Evidence-Based Criteria for Patient Selection: Case Report and Review of Literature by Foster, Deshka, Shaikh, Mohammad F, Gleeson, Elizabeth, Babcock, Blake D, Ringold, Daniel, Bowne, Wilbur B

“…Criteria for selecting patients with advanced cancer for palliative surgery (PS) remains poorly defined. Decision making for PS requires realistic treatment…”
Get more information

MDM-2 Overexpression in Human Stem-Like and Mature Colon Cancer Cells as a Target for Anti-Cancer Therapy: Steps toward a Translational Model by Shaikh, Mohammad F., MD, Babcock, Blake D., MD, Gleeson, Elizabeth, MD, MPH, Love, Patrice, Davitt, Katlin, Piazza, Yelena, MD, Foster, Deshka, MD, Meckmongkol, Teerin, MD, PhD, Pincus, Matthew R., MD, PhD, Bowne, Wilbur B., MD, FACS

Get full text

The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells by Davitt, Katlin, Babcock, Blake D, Fenelus, Maly, Poon, Chi Kong, Sarkar, Abhishek, Trivigno, Vincent, Zolkind, Paul A, Matthew, Sheena M, Grin'kina, Natalia, Orynbayeva, Zulfiya, Shaikh, Mohammad F, Adler, Victor, Michl, Josef, Sarafraz-Yazdi, Ehsan, Pincus, Matthew R, Bowne, Wilbur B

“…We have developed the anti-cancer peptide, PNC-27, which is a membrane-active peptide that binds to the HDM-2 protein expressed in the cancer cell membranes of…”
Get more information

Pancreatic mucinous cystic neoplasm in a transgender patient by Foster, Deshka, Shaikh, Mohammad F, Gleeson, Elizabeth, Babcock, Blake D, Lin, Jianping, Ownbey, Robert T, Hysell, Mark E, Ringold, Daniel, Bowne, Wilbur B

“…Cystic pancreatic lesions are increasingly more frequent detected clinical entities. Mucinous cystic neoplasm (MCN) is a hormone-related pancreatic tumor…”
Get full text

Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity by Williams, Austin D, Sanchez, Adriana, Hou, Jun Steve, Rubin, Rene Rothstein, Hysell, Mark E, Babcock, Blake D, Shaikh, Mohammad F, Weingarten, Michael S, Bowne, Wilbur B

“…Castleman's disease is a rare and poorly understood disease entity that may resemble more common conditions and represents a clinical challenge to the treating…”
Get full text